Tranoclot 500
Tranexamic Acid (500mg)

About this product
Rapid, Reliable Antifibrinolytic Action, with Proven Mortality Benefit When Given Early.

Overview
Tranoclot 500 offers a well-documented reduction in surgical blood loss and the associated need for transfusion, with benefits established across multiple surgical specialties when the drug is used according to institutional protocol. Given intravenously, it acts quickly, making it a dependable option in acute haemorrhagic emergencies where fast, reliable control of bleeding is critical. Beyond its clinical performance, Tranoclot 500 also brings decades of real-world use behind it, having served as a low-cost, established addition to standard haemorrhage-management bundles across a wide range of clinical settings over the years.
Indications
Partner With Schemic Concepts
Engineer better health outcomes with precision-driven pharmaceuticals
Healthcare is moving toward greater digital integration and evidence-based care. Schemic Concepts is built to move with it
